THERACLONE SCIENCES
Theraclone Sciences (formerly Spaltudaq) is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The company's technology harnesses the power of the human immune system to identify naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Recombinant human monoclonal antibodies can be rapidly obtained using our discovery platform and scaled for la... rge-scale industrial production. Such antibody drug candidates may be uniquely important in combating disease and may have potential as therapeutic products that can be administered to a broad patient population. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.
THERACLONE SCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2004-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.theraclone-sciences.com
Total Employee:
11+
Status:
Active
Contact:
(206) 805-1600
Email Addresses:
[email protected]
Total Funding:
63.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail
Similar Organizations
Abacus Bioscience
Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers.
Amakem
Amakem is a kinase platform company developing therapeutics for the treatment of serious eye conditions.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Connect Biopharmaceuticals
Connect Biopharma is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Emphasys Medical
Emphasys Medical develops therapeutic devices for the treatment of patients with emphysema and other breathing disorders.
Epicyte Pharmaceuticals
Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.
Nereus Pharmaceuticals
Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.
Park Therapeutics
Park Therapeutics, a company developing a unique, first-in-class, investigational NCE for the treatment of pain which is Phase III-ready.
Sound Alignment
Sound Alignment is a web portal that enables vibration based therapeutics studies to be a remotely function via mobile devices.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Wise Anderson Protocol
The Wise-Anderson Protocol was developed at Stanford University in the Department of Urology by David Wise, Ph.D. and Rodney Anderson M.D.
Current Advisors List
Current Employees Featured
Founder
Investors List
Amgen Ventures
Amgen Ventures investment in Series B - Theraclone Sciences
MidCap Financial
MidCap Financial investment in Debt Financing - Theraclone Sciences
MPM Capital
MPM Capital investment in Series B - Theraclone Sciences
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Theraclone Sciences
Versant Ventures
Versant Ventures investment in Series B - Theraclone Sciences
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Theraclone Sciences
Zenyaku Kogyo
Zenyaku Kogyo investment in Series B - Theraclone Sciences
Canaan Partners
Canaan Partners investment in Series B - Theraclone Sciences
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series B - Theraclone Sciences
HealthCare Ventures
HealthCare Ventures investment in Series B - Theraclone Sciences
Official Site Inspections
http://www.theraclone-sciences.com
- Host name: 55.245.178.68.host.secureserver.net
- IP address: 68.178.245.55
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Theraclone Sciences"
Theraclone Sciences
Theraclone Sciences. 1124 Columbia Street, Suite 300. Seattle, WA 98104. P: 206.805.1600. F: 206.805.1699See details»
Theraclone Sciences - Crunchbase Company Profile & Funding
Organization. Theraclone Sciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Theraclone Sciences is a biotech …See details»
Theraclone Sciences Company Profile 2024: Valuation, …
Theraclone Sciences General Information Description. Developer of therapeutic antibodies discovery platform intended to discover monoclonal antibodies. The …See details»
THERACLONE SCIENCES INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for THERACLONE SCIENCES INC of Seattle, WA. Get the latest business insights from Dun & …See details»
Theraclone Sciences Company Profile - Office Locations ... - Craft
Theraclone Sciences, a discovery-stage biotech company, develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. It provides In-Situ Therapeutic Antibody …See details»
Theraclone Sciences - Products, Competitors, Financials, …
Theraclone Sciences is involved in the discovery and development of human monoclonal antibodies for therapeutic use. The company employs screening technology to identify …See details»
Theraclone Sciences - Org Chart, Teams, Culture & Jobs - The Org
Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the treatment of infectious diseases and inflammation. Industries. Biotechnology, Health Care +1. …See details»
Theraclone Sciences | VentureRadar
Theraclone Sciences is a Seattle-based biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The Company's I-STAR? …See details»
Theraclone Sciences - Funding, Financials, Valuation & Investors
Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the treatment of infectious diseases and inflammation. Search Crunchbase. Start Free Trial . …See details»
Theraclone Sciences - Company Profile - Tracxn
Nov 27, 2024 Theraclone Sciences - Develops therapeutic antibodies for the treatment of infectious disease and cancer.. Raised a total funding of $61.2M over 8 rounds from 10 …See details»
Theraclone Sciences | Funding, Valuation & Investors | Finallot
Explore Theraclone Sciences profile on Finallot for insights on its team, products, and industry - Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the …See details»
Theraclone Sciences - Seattle, USA - bionity.com
Theraclone Sciences is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The …See details»
Theraclone Sciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Clinical Trials associated with Theraclone Sciences, Inc. RBR-8gcx9m / Recruiting Phase 2 A phase 2a single arm study to evaluate the effect of TCN -202 (human anti-cytomegalovirus …See details»
Theraclone Sciences - Contacts, Employees, Board Members
Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the treatment of infectious diseases and inflammation. ... Solutions. Products. Resources. Pricing. …See details»
Theraclone Sciences CEO, Founder, Key Executive Team, Board of ...
Theraclone Sciences has 3 board of directors, including Christopher Mirabelli. Name. Firm. Work History. ... United Biomedical is a biopharmaceutical organization that develops diagnostics …See details»
THERACLONE SCIENCES Revenue, Growth & Competitor Profile
Determine whether Theraclone Sciences grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession …See details»
Theraclone Sciences - Scientist.com
Theraclone Sciences Columbia St #300 Phillips, TX, 79553 United States: ... If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If …See details»
Theraclone Sciences Lands $55.5M in Series B Funding
Biotech therapy developer Theraclone Sciences has raised an additional $14 million in Series B financing, including $8 million in equity from current investors, including ARCH Venture …See details»
Theraclone, Pfizer Ink Antibody Agreement Worth up to $632M
Oct 31, 2011 Privately held Theraclone Sciences Inc., of Seattle, has grabbed a tiger by the tail, inking a multiyear research and development collaboration with Pfizer Inc. for the company's in …See details»
Theraclone Sciences - VentureRadar
Theraclone Sciences is a Seattle-based biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The Company's I-STAR? …See details»